Frank Stenner

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 3

Top Topics

Mesenchymal Stem Cells

Clinical Practice

Ejection Fraction

Top Venues

Cancer immunology research

Targeted oncology

This page only lists publications with an associated author ORCID identifier.

Publications

David König, Michael T Sandholzer, Sarp Uzun, Andreas Zingg, Reto Ritschard, Helen Thut, Katharina Glatz, Elisabeth Artemis Kappos, Dirk J Schaefer, Christoph Kettelhack, Jakob R Passweg, Andreas Holbro, Katharina Baur, Michael Medinger, Andreas S Buser, Didier Lardinois, Lukas T Jeker, Nina Khanna, Frank Stenner, Benjamin Kasenda, Krisztian Homicsko, Matthias S Matter, Natalia Rodrigues Mantuano, Alfred Zippelius, Heinz Laubli
Melanoma Clonal Heterogeneity Leads to Secondary Resistance after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes. Cancer immunology research 12 (7) (2024)
David König, Michael T Sandholzer, Sarp Uzun, Andreas Zingg, Reto Ritschard, Helen Thut, Katharina Glatz, Elisabeth Artemis Kappos, Dirk J Schaefer, Christoph Kettelhack, Jakob R Passweg, Andreas Holbro, Katharina Baur, Michael Medinger, Andreas S Buser, Didier Lardinois, Lukas T Jeker, Nina Khanna, Frank Stenner, Benjamin Kasenda, Krisztian Homicsko, Matthias S Matter, Natalia Rodrigues Mantuano, Alfred Zippelius, Heinz Laubli
Melanoma clonal heterogeneity leads to secondary resistance after adoptive cell therapy with tumor-infiltrating lymphocytes. Cancer immunology research (2024)
Heike Liewen, Norbert Markuly, Heinz Läubli, Yang Liu, Matthias S Matter, Nora Liewen, Christoph Renner, Alfred Zippelius, Frank Stenner
Therapeutic Targeting of Golgi Phosphoprotein 2 (GOLPH2) with Armed Antibodies: A Preclinical Study of Anti-GOLPH2 Antibody Drug Conjugates in Lung and Colorectal Cancer Models of Patient Derived Xenografts (PDX). Targeted oncology 14 (5) (2020)